Cargando…
A commentary on TREAT: The trial of early aggressive drug therapy in juvenile idiopathic arthritis
Polyarticular juvenile idiopathic arthritis (JIA) is a category of JIA where multiple joints are affected by chronic inflammation, and where serious and lasting damage to joints is the expected natural history in untreated disease. There is evidence of response to disease-modifying antirheumatic and...
Autor principal: | Baildam, Eileen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398843/ https://www.ncbi.nlm.nih.gov/pubmed/22694995 http://dx.doi.org/10.1186/1741-7015-10-59 |
Ejemplares similares
-
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
por: Zaripova, Lina N., et al.
Publicado: (2021) -
Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019) -
Intra-articular corticosteroid injections in juvenile idiopathic arthritis
por: Carrasco, Roberto, et al.
Publicado: (2014) -
Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008) -
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2022)